These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. A long-term review of the treatment of patients with Ewing's sarcoma in one institution. Sluga M, Windhager R, Lang S, Heinzl H, Krepler P, Mittermayer F, Dominkus M, Zoubek A, Kotz R. Eur J Surg Oncol; 2001 Sep 15; 27(6):569-73. PubMed ID: 11520091 [Abstract] [Full Text] [Related]
9. Interactomic approach for evaluating nucleophosmin-binding proteins as biomarkers for Ewing's sarcoma. Haga A, Ogawara Y, Kubota D, Kitabayashi I, Murakami Y, Kondo T. Electrophoresis; 2013 Jun 15; 34(11):1670-8. PubMed ID: 23483572 [Abstract] [Full Text] [Related]
10. Absence of HER2/neu gene expression in osteosarcoma and skeletal Ewing's sarcoma. Thomas DG, Giordano TJ, Sanders D, Biermann JS, Baker L. Clin Cancer Res; 2002 Mar 15; 8(3):788-93. PubMed ID: 11895910 [Abstract] [Full Text] [Related]
11. Clinical significance of tumor protein D52 immunostaining in a large series of Ewing's sarcoma family of tumors. Machado I, López-Guerrero JA, Calabuig-Fariñas S, Hardy JR, Scotlandi K, Picci P, Byrne JA, Llombart-Bosch A. Pediatr Dev Pathol; 2011 Mar 15; 14(3):255-6. PubMed ID: 21338318 [No Abstract] [Full Text] [Related]
12. Induction of cell death by basic fibroblast growth factor in Ewing's sarcoma. Sturla LM, Westwood G, Selby PJ, Lewis IJ, Burchill SA. Cancer Res; 2000 Nov 01; 60(21):6160-70. PubMed ID: 11085540 [Abstract] [Full Text] [Related]
13. Expression of functional CD40 on human osteosarcoma and Ewing's sarcoma cells. Lollini PL, Landuzzi L, Frabetti F, Rossi I, Nicoletti G, Scotlandi K, Serra M, Baldini N, De Giovanni C, Nanni P. Clin Cancer Res; 1998 Aug 01; 4(8):1843-9. PubMed ID: 9717810 [Abstract] [Full Text] [Related]
14. Ewing's sarcoma of jaw bones in adult patients: 10-year experiences in a Paris university hospital. Pitak-Arnnop P, Bellefqih S, Bertolus C, Chaine A, Dhanuthai K, Gruffaz F, Bertrand JC. J Craniomaxillofac Surg; 2008 Dec 01; 36(8):450-5. PubMed ID: 18674924 [Abstract] [Full Text] [Related]
15. Immunophenotypic profile of biomarkers related to anti-apoptotic and neural development pathways in the Ewing's family of tumors (EFT) and their therapeutic implications. Navarro S, Giraudo P, Karseladze AI, Smirnov A, Petrovichev N, Savelov N, Alvarado-Cabrero I, Llombart-Bosch A. Anticancer Res; 2007 Dec 01; 27(4B):2457-63. PubMed ID: 17695539 [Abstract] [Full Text] [Related]
17. Ewing's sarcoma: value of tumor necrosis as a predictive factor. de Stéfani E, Carzoglio J, Deneo Pellegrini H, Olivera L, Cendan M, Kasdorf H. Bull Cancer; 1984 Dec 01; 71(1):16-21. PubMed ID: 6713111 [Abstract] [Full Text] [Related]
18. Clinical significance of Vascular Endothelial Growth Factor-A expression in Ewing's sarcoma. Kreuter M, Paulussen M, Boeckeler J, Gerss J, Buerger H, Liebscher C, Kessler T, Jurgens H, Berdel WE, Mesters RM. Eur J Cancer; 2006 Aug 01; 42(12):1904-11. PubMed ID: 16824746 [Abstract] [Full Text] [Related]
19. Xg expression in Ewing's sarcoma is of prognostic value and contributes to tumor invasiveness. Meynet O, Scotlandi K, Pradelli E, Manara MC, Colombo MP, Schmid-Antomarchi H, Picci P, Bernard A, Bernard G. Cancer Res; 2010 May 01; 70(9):3730-8. PubMed ID: 20388798 [Abstract] [Full Text] [Related]
20. [Clinicopathological study of Ewing's sarcoma/primitive neuroectodermal tumor in oral and maxillofacial region]. He HW, Liu LK, Li YN, Wang D, He ZX. Zhonghua Kou Qiang Yi Xue Za Zhi; 2005 Sep 01; 40(5):379-82. PubMed ID: 16255919 [Abstract] [Full Text] [Related] Page: [Next] [New Search]